Similar articles for PMID: 30194159

Year	Number of Results
1951	1
1952	1
1953	1
1997	1
1999	2
2004	1
2010	3
2011	5
2012	6
2013	15
2014	15
2015	23
2016	18
2017	13
2018	7
2019	3
2020	1
2021	1
2023	0

1

Prognostic Value of Serum Creatinine Levels in Patients with Epithelial Ovarian Cancer.

Lafleur J, Hefler-Frischmuth K, Grimm C, Schwameis R, Gensthaler L, Reiser E, Hefler LA. Lafleur J, et al. Anticancer Res. 2018 Sep;38(9):5127-5130. doi: 10.21873/anticanres.12834. Anticancer Res. 2018. PMID: 30194159

2

Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.

Masoumi-Moghaddam S, Amini A, Wei AQ, Robertson G, Morris DL. Masoumi-Moghaddam S, et al. Oncotarget. 2015 Sep 29;6(29):28491-501. doi: 10.18632/oncotarget.4427. Oncotarget. 2015. PMID: 26143638 Free PMC article.

3

Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.

Huo J, Hu J, Liu G, Cui Y, Ju Y. Huo J, et al. Arch Gynecol Obstet. 2017 Feb;295(2):459-465. doi: 10.1007/s00404-016-4258-8. Epub 2016 Dec 14. Arch Gynecol Obstet. 2017. PMID: 27975129

4

Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.

Pylväs-Eerola M, Karihtala P, Puistola U. Pylväs-Eerola M, et al. BMC Cancer. 2015 Jul 2;15:493. doi: 10.1186/s12885-015-1504-6. BMC Cancer. 2015. PMID: 26134400 Free PMC article.

5

The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer.

Ayhan A, Günakan E, Alyazıcı İ, Haberal N, Altundağ Ö, Dursun P. Ayhan A, et al. Arch Gynecol Obstet. 2017 Nov;296(5):989-995. doi: 10.1007/s00404-017-4511-9. Epub 2017 Sep 5. Arch Gynecol Obstet. 2017. PMID: 28875365

6

MAGE-A family serves as poor prognostic markers and potential therapeutic targets for epithelial ovarian cancer patients: a retrospective clinical study.

Sang M, Wu X, Fan X, Lian Y, Sang M. Sang M, et al. Gynecol Endocrinol. 2017 Jun;33(6):480-484. doi: 10.1080/09513590.2017.1291611. Epub 2017 Feb 28. Gynecol Endocrinol. 2017. PMID: 28277121

7

Prognostic value of preoperative hyponatremia and thrombocytosis in patients with epithelial ovarian cancer.

Hefler-Frischmuth K, Grimm C, Gensthaler L, Reiser E, Schwameis R, Hefler LA. Hefler-Frischmuth K, et al. Wien Klin Wochenschr. 2018 Oct;130(19-20):575-580. doi: 10.1007/s00508-018-1388-y. Epub 2018 Sep 3. Wien Klin Wochenschr. 2018. PMID: 30178070

8

Serum relaxin as a diagnostic and prognostic marker in patients with epithelial ovarian cancer.

Guo X, Liu Y, Huang X, Wang Y, Qu J, Lv Y. Guo X, et al. Cancer Biomark. 2017 Dec 12;21(1):81-87. doi: 10.3233/CBM-170278. Cancer Biomark. 2017. PMID: 29060928

9

Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer.

Komatsu H, Oishi T, Itamochi H, Shimada M, Sato S, Chikumi J, Sato S, Nonaka M, Sawada M, Wakahara M, Umekita Y, Harada T. Komatsu H, et al. Int J Gynecol Cancer. 2017 Sep;27(7):1325-1332. doi: 10.1097/IGC.0000000000001027. Int J Gynecol Cancer. 2017. PMID: 28557832

10

Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.

Luo Y, Kim HS, Kim M, Lee M, Song YS. Luo Y, et al. J Gynecol Oncol. 2017 May;28(3):e36. doi: 10.3802/jgo.2017.28.e36. Epub 2017 Mar 7. J Gynecol Oncol. 2017. PMID: 28382799 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed